NRSNW
NeuroSense Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.05
+0.00%Leverage
- Debt / equity
- -0.11x
- Net debt / equity
- -0.00x
- Debt / assets
- 0.17x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- -0.00x
Liquidity & coverage
- Current ratio
- 0.31x
- Quick ratio
- 0.31x
- Cash ratio
- 0.07x
- Interest coverage
- -652.06x
- EBITDA / interest
- -651.12x
- Working capital
- -$1.7M
Cash & dividend
- FCF / debt
- -21.62x
- Cash flow / debt
- -21.61x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025